Literature DB >> 28012091

Hypocretins and Arousal.

Shi-Bin Li1, William J Giardino1, Luis de Lecea2.   

Abstract

How the brain controls vigilance state transitions remains to be fully understood. The discovery of hypocretins, also known as orexins, and their link to narcolepsy has undoubtedly allowed us to advance our knowledge on key mechanisms controlling the boundaries and transitions between sleep and wakefulness. Lack of function of hypocretin neurons (a relatively simple and non-redundant neuronal system) results in inappropriate control of sleep states without affecting the total amount of sleep or homeostatic mechanisms. Anatomical and functional evidence shows that the hypothalamic neurons that produce hypocretins/orexins project widely throughout the entire brain and interact with major neuromodulator systems in order to regulate physiological processes underlying wakefulness, attention, and emotions. Here, we review the role of hypocretins/orexins in arousal state transitions, and discuss possible mechanisms by which such a relatively small population of neurons controls fundamental brain state dynamics.

Entities:  

Keywords:  Hypocretin; Narcolepsy; Outputs of hypocretin neurons; Probabilistic model of sleep and wake; Sleep-arousal transition

Mesh:

Substances:

Year:  2017        PMID: 28012091     DOI: 10.1007/7854_2016_58

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  7 in total

1.  Optical probing of orexin/hypocretin receptor antagonists.

Authors:  Shi-Bin Li; Natalie Nevárez; William J Giardino; Luis de Lecea
Journal:  Sleep       Date:  2018-10-01       Impact factor: 5.849

2.  Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil.

Authors:  Aida Mohammadkhani; Jennifer E Fragale; Caroline B Pantazis; Hannah E Bowrey; Morgan H James; Gary Aston-Jones
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

Review 3.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

4.  Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence.

Authors:  Alessandra Matzeu; Marsida Kallupi; Olivier George; Paul Schweitzer; Rémi Martin-Fardon
Journal:  Neuropsychopharmacology       Date:  2017-10-20       Impact factor: 7.853

5.  Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.

Authors:  Rhîannan H Williams; Tomomi Tsunematsu; Alexia M Thomas; Kelsie Bogyo; Akihiro Yamanaka; Thomas S Kilduff
Journal:  J Neurosci       Date:  2019-10-18       Impact factor: 6.167

6.  Extended Amygdala Neuropeptide Circuitry of Emotional Arousal: Waking Up on the Wrong Side of the Bed Nuclei of Stria Terminalis.

Authors:  William J Giardino; Matthew B Pomrenze
Journal:  Front Behav Neurosci       Date:  2021-02-09       Impact factor: 3.558

7.  Parallel circuits from the bed nuclei of stria terminalis to the lateral hypothalamus drive opposing emotional states.

Authors:  William J Giardino; Ada Eban-Rothschild; Daniel J Christoffel; Shi-Bin Li; Robert C Malenka; Luis de Lecea
Journal:  Nat Neurosci       Date:  2018-07-23       Impact factor: 24.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.